T
RXII

TradeWorx’s GALENA BIOPHARMA INC COM RXII Stock Holding History

TradeWorx’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-15,497
Closed -$47K – 456
2014
Q2 		$47K Buy
+15,497
New +$47K 0.04% 308

Other funds holding RXII

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

TradeWorx's RXII Position: Q3 2014 in Review

TradeWorx sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2014, closing a stake of 15,497 shares — an estimated $47K sold.

TradeWorx first reported a position in RXII in Q2 2014 and held it in 1 quarter. The position peaked at $47K in Q2 2014. 85 funds tracked by Wall St. Rank hold RXII as of Q3 2014.

  • TradeWorx reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2014 after selling out during the quarter.
  • TradeWorx sold 15,497 GALENA BIOPHARMA INC COM shares in Q3 2014, an estimated $47K.
  • TradeWorx first reported a position in GALENA BIOPHARMA INC COM in Q2 2014 and held it in 1 quarter.
  • TradeWorx's GALENA BIOPHARMA INC COM position peaked at $47K in Q2 2014.
  • 85 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2014.

Based on TradeWorx's 13F filing for Q3 2014, filed 1 Oct 2014.